HIV Redirecting Innate Immunity by Vpu Targeting of JAK1
HIV 通过 Vpu 靶向 JAK1 重定向先天免疫
基本信息
- 批准号:10619889
- 负责人:
- 金额:$ 7.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-20 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:Amino Acid MotifsBiochemicalCD4 Positive T LymphocytesCell physiologyCellsCellular ImmunityCellular biologyCytokine ReceptorsCytokine SignalingDataDendritic CellsDetectionGenesGoalsHIVHIV InfectionsImmune responseImmune systemImmunityInfectionInnate Immune ResponseInnate Immune SystemInterferon Type IInterferon Type IIInterferonsJAK1 geneLinkLysosomesMapsMediatingMethodsMutation AnalysisNamesNatural ImmunityOutcomePathogenesisPatientsPersonsPhenotypePhosphorylationProductionProteinsRefractoryResearch Project GrantsSTAT1 geneSerumSignal TransductionSystemT-LymphocyteTechniquesTertiary Protein StructureUbiquitinationViralVirusVirus DiseasesVirus ReplicationWorkadaptive immunityantiviral immunityarmcellular targetingcytokinedomain mappingexperienceimmune clearanceinsightmulticatalytic endopeptidase complexresponsetumor-immune system interactionsvpu Protein
项目摘要
Project Summary/Abstract
It is well known that the pathogenesis of HIV is intricately linked to the immune system. For HIV to promote its
replication and long-term infection HIV must also modulate cytokine signaling to manipulate the immune
microenvironment HIV is existing in. In our previous work we have found that HIV has encoded accessory
genes that are able to block the action of the important innate antiviral cytokine named Type I Interferon. Type
I Interferons were named for their ability to interfere with the replication of viruses and HIV has encoded
multiple ways to block this cytokine. The overall goal of this R03 application is to determine how one of the
HIV-encoded genes that blocks Type I Interferon can block this signaling in T cells, the major cell infected by
HIV. Long term, this work is critical to set the stage to better understand how HIV sustains itself in a person
and avoids elimination by the innate immune system.
项目摘要/摘要
众所周知,艾滋病毒的发病机制与免疫系统有着千丝万缕的联系。让艾滋病毒促进其
复制和长期感染HIV还必须调节细胞因子信号来操纵免疫
艾滋病病毒存在的微环境。在我们之前的工作中,我们发现HIV编码了附件
能够阻止重要的先天抗病毒细胞因子I型干扰素的作用的基因。类型
I干扰素之所以被命名是因为它们能够干扰病毒的复制,而艾滋病毒已经编码了
有多种方法可以阻断这种细胞因子。此R03应用程序的总体目标是确定其中一个
阻断I型干扰素的HIV编码基因可以阻断T细胞中的这种信号,T细胞是感染病毒的主要细胞
爱滋病毒。从长远来看,这项工作对于为更好地了解艾滋病毒如何在人身上自我维持奠定了基础
并避免被先天免疫系统清除。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID JESSE SANCHEZ其他文献
DAVID JESSE SANCHEZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID JESSE SANCHEZ', 18)}}的其他基金
Disruption of Type I Interferon Induction by a KSHV Homologue of IPS-1
IPS-1 的 KSHV 同系物对 I 型干扰素诱导的破坏
- 批准号:
10258718 - 财政年份:2021
- 资助金额:
$ 7.15万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 7.15万 - 项目类别:
Continuing Grant
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Standard Grant
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Operating Grants
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
- 批准号:
22KJ2600 - 财政年份:2023
- 资助金额:
$ 7.15万 - 项目类别:
Grant-in-Aid for JSPS Fellows














{{item.name}}会员




